U.S. Food and Drug Administration

Featured

Rare Disease Day: March 1

A rare disease affects 200,000 people or fewer in the U.S. Rare diseases collectively affect over 30 million people in the U.S. Learn more about FDA’s Rare Disease Day, a virtual public meeting, on March 1, 2024.

COVID-19, Flu and RSV

Your guide to FDA-authorized and approved vaccines, tests and treatments for all three illnesses.

A person reading information on the computer.

Help Stop the Spread of Misinformation

You can help. Get the facts from the FDA. Stop the spread of false rumors, and share the facts with your loved ones.

Drug Shortages

FDA works closely with manufacturers to prevent or reduce the impact of drug shortages.

Food

Drugs

Medical Devices

Radiation-Emitting Products

Vaccines, Blood, and Biologics

Animal and Veterinary

Cosmetics

Tobacco Products

Mar 01

FDA Roundup: March 1, 2024

Feb 28

FDA, Industry Actions End Sales of PFAS Used in US Food Packaging

More Press Announcements

Newsroom Meetings Testimony Speeches

Feb 29

Megadyne Reiterates Intended Use Population Change for Megadyne Mega Soft Universal and Universal Plus Patient Return Electrodes

Medical Devices

Feb 28

Electric City Sweets Issues Allergy Alert On Undeclared Milk in Electric City Sweet 1.75oz Red Velvet Milk Chocolate Bars

Food & Beverages

Feb 27

Roland Foods, LLC Recalls Roland® Tahini (100% Ground Sesame Seeds) 16 Oz. Because of Possible Health Risk

Food & Beverages

More Recalls Market Withdrawals & Safety Alerts Subscribe to the Enforcement Report Mailing List

Paragraph Header

Image depicts a patient smiling and confidently conversing with her doctor.

FDA Works to Make Informed Consent Easier to Understand

FDA and the Office for Human Research Protections have published a draft guidance: “Key Information and Facilitating Understanding in Informed Consent.”

Monochromatic blue themed image that depicts a doctor's hand touching a patients shoulders, test tubes and a group of hands piled up on one another.

FDA Helps to Deliver Meaningful Advances for Rare Disease Patients

FDA’s Rare Disease Day Meeting on March 1 Dedicated to Patients and Health Care Professionals

Photo of Office of Generic Drugs 2023 Annual Report on table top.

FDA Science, Research, and Collaboration Advance Generic Medicines

In 2023, GDUFA-funded research helped expand our understanding of generic drug products, including complex products.

Mar 01

Clinical Pharmacology Considerations for Antibody-Drug Conjugates Guidance for Industry

Biologics, Drugs

Feb 29

Key Information and Facilitating Understanding in Informed Consent Guidance for Sponsors, Investigators, and Institutional Review Boards

Drugs

Feb 26